Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Fourth Quarter and Year End 2011 Financial Results
February 01, 2012 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals Motion for Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd. Stayed
January 26, 2012 13:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Jan. 26, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta to Host Investor Conference Call on December 23, 2011 to Discuss Follow-On Biologics Collaboration With Baxter
December 22, 2011 16:19 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 22, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals
December 05, 2011 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
TIME CHANGE: Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
December 01, 2011 14:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Dec. 1, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Present at the 2011 Deutsche Bank BioFEST
November 28, 2011 17:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Reports $1.18 Earnings per Share for the Third Quarter of 2011
November 07, 2011 08:51 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Obtains Preliminary Injunction Against Amphastar Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and International Medical Systems, Ltd.
October 28, 2011 16:47 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces That Launch of Authorized Generic Lovenox(R) Triggers Change in Collaboration Terms
October 24, 2011 17:13 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2011 Financial Results
October 24, 2011 10:45 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...